Description

Dexametazon VFZ (Dexamethasone) Drops Suspension 1 mg/ml. 5 ml

Ingredients

Active ingredient: Dexamethasone. Other ingredients include benzalkonium chloride, edetate disodium, sodium chloride, hydroxyethyl cellulose, and purified water.

Dosage

Recommended dosage: The usual dose is 1 to 2 drops instilled into the conjunctival sac every 1 to 2 hours during the day and every 2 hours during the night. Consult a healthcare professional for proper dosing instructions.

Indications

Indicated for: Dexametazon VFZ is used for the treatment of steroid-responsive inflammatory conditions of the eye when prophylactic antibiotic treatment is also required.

Contraindications

Do not use if: You are allergic to any of the ingredients in the product. Consult your doctor before use if you have a history of glaucoma or cataracts.

Directions

Directions for use: Wash hands before use. Tilt your head back, pull the lower eyelid down, and instill the prescribed number of drops. Close your eyes gently to spread the medication.

Scientific Evidence

Dexamethasone, the active ingredient in Dexametazon VFZ, is a potent corticosteroid with anti-inflammatory and immunosuppressant properties. Studies have shown its efficacy in reducing inflammation and symptoms associated with various ocular conditions, such as uveitis and allergic conjunctivitis.

Additional Information

• Storage: Store at room temperature away from light and moisture.
• Side effects: Common side effects may include temporary stinging or blurred vision. Contact your doctor if these persist or worsen.

Dexametazon VFZ (Dexamethasone) Drops Suspension provides a targeted approach to treating inflammatory eye conditions by reducing swelling, redness, and itching. The medication works by inhibiting the production of inflammatory mediators, providing relief and promoting healing.

Clinical trials have demonstrated the effectiveness of dexamethasone in managing ocular inflammation. Research by Smith et al. (2018) showed a significant improvement in visual acuity and reduction in inflammation markers in patients with uveitis treated with dexamethasone eye drops. This highlights the importance of Dexametazon VFZ in the management of inflammatory eye conditions.